Christian Klein,Vaios Karanikas,Pablo Umana,Alfred Zippelius,Daniela Thommen,Jens Schreiner
申请号：
US15600011
公开号：
US20170349666A1
申请日:
2017.05.19
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention generally relates to T cell activating bispecific antigen binding molecules, PD-1 axis binding antagonists, and in particular to combination therapies employing such T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists, and their use of these combination therapies for the treatment of cancer.
